62.57
                                            
                                Overview
                                News
                                Price History
                                    Option Chain
                                Financials
                                Discussions
                                Forecast
                                    Stock Split
                                    Dividend History
                        
                        
            Bio Techne Corp stock is traded at $62.57, with a volume of 2.11M.
            It is up +2.64% in the last 24 hours and up +12.48% over the past month.
            Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
        
        See More
    Previous Close:
              $60.96
            Open:
              $60.81
            24h Volume:
                2.11M
            Relative Volume:
              0.92
            Market Cap:
                $9.74B
            Revenue:
              $1.17B
            Net Income/Loss:
              $150.71M
            P/E Ratio:
              66.56
            EPS:
                0.94
            Net Cash Flow:
                $245.03M
            1W Performance:
              -5.06%
            1M Performance:
              +12.48%
            6M Performance:
                +24.27%
            1Y Performance:
              -15.16%
            Bio Techne Corp Stock (TECH) Company Profile
Name
                  
                      Bio Techne Corp
                    
                Sector
                  Industry
                  Phone
                  
                      (612) 379-8854
                    
                Address
                  
                      614 MCKINLEY PL N E, MINNEAPOLIS, MN
                    
                Compare TECH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                TECH
                            
                             Bio Techne Corp | 62.57 | 9.49B | 1.17B | 150.71M | 245.03M | 0.94 | 
|   
                          
                                VRTX
                            
                             Vertex Pharmaceuticals Inc | 425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 | 
|   
                          
                                REGN
                            
                             Regeneron Pharmaceuticals Inc | 651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 | 
|   
                          
                                ALNY
                            
                             Alnylam Pharmaceuticals Inc | 456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 | 
|   
                          
                                ARGX
                            
                             Argen X Se Adr | 818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 | 
|   
                          
                                INSM
                            
                             Insmed Inc | 189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 | 
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change | 
|---|---|---|---|
| Sep-03-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform | 
| Aug-21-25 | Upgrade | Citigroup | Neutral → Buy | 
| Jul-22-25 | Resumed | Stephens | Overweight | 
| Jul-09-25 | Initiated | TD Cowen | Buy | 
| May-30-25 | Initiated | Wells Fargo | Overweight | 
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight | 
| Mar-18-25 | Initiated | Evercore ISI | Outperform | 
| Feb-19-25 | Downgrade | Robert W. Baird | Outperform → Neutral | 
| May-22-24 | Downgrade | Citigroup | Buy → Neutral | 
| Feb-08-24 | Initiated | Scotiabank | Sector Outperform | 
| Feb-02-24 | Downgrade | Stifel | Buy → Hold | 
| Dec-07-23 | Initiated | UBS | Buy | 
| Aug-28-23 | Initiated | William Blair | Outperform | 
| Jan-10-23 | Upgrade | Wells Fargo | Underweight → Equal Weight | 
| Dec-14-22 | Initiated | Deutsche Bank | Buy | 
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy | 
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform | 
| Aug-25-22 | Initiated | Credit Suisse | Outperform | 
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight | 
| Sep-15-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight | 
| Mar-08-21 | Upgrade | Stephens | Equal-Weight → Overweight | 
| Feb-23-21 | Upgrade | Stifel | Hold → Buy | 
| Jan-25-21 | Reiterated | The Benchmark Company | Buy | 
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight | 
| Sep-30-20 | Initiated | Atlantic Equities | Overweight | 
| Jul-15-20 | Downgrade | Stephens | Overweight → Equal-Weight | 
| May-27-20 | Downgrade | Stifel | Buy → Hold | 
| May-14-20 | Initiated | The Benchmark Company | Buy | 
| Jan-08-20 | Resumed | Stephens | Overweight | 
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight | 
| Jan-07-20 | Initiated | Citigroup | Neutral | 
| Nov-15-19 | Initiated | Stifel | Buy | 
| Jul-02-19 | Upgrade | Janney | Neutral → Buy | 
| Jan-14-19 | Upgrade | Stephens | Equal-Weight → Overweight | 
| Oct-31-18 | Downgrade | Craig Hallum | Buy → Hold | 
| Oct-17-18 | Initiated | Goldman | Neutral | 
| Jun-15-18 | Initiated | Argus | Buy | 
| Jul-13-17 | Initiated | Wells Fargo | Market Perform | 
| Feb-09-17 | Initiated | Citigroup | Buy | 
| Jan-18-17 | Initiated | Deutsche Bank | Buy | 
| Nov-10-16 | Resumed | Leerink Partners | Outperform | 
| Jan-21-15 | Reiterated | Robert W. Baird | Outperform | 
| Sep-20-13 | Upgrade | Robert W. Baird | Neutral → Outperform | 
                    View All
                     
                  
                Bio Techne Corp Stock (TECH) Latest News
Is Bio Techne Corporation stock a contrarian buyJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Why Bio Techne Corporation (TE1) stock could outperform next yearTrade Analysis Summary & Safe Swing Trade Setups - newser.com
Statistical indicators supporting Bio Techne Corporation’s strength2025 Risk Factors & Free Long-Term Investment Growth Plans - newser.com
Published on: 2025-10-31 01:10:28 - newser.com
How to forecast Bio Techne Corporation trends using time seriesQuarterly Profit Report & Daily Market Momentum Tracking - newser.com
Will Bio Techne Corporation (TE1) stock hit Wall Street targetsCEO Change & Verified Technical Signals - newser.com
Bio-Techne Corp. Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Is Bio Techne Corporation (TE1) stock overpriced at current multiplesJuly 2025 Review & Weekly Breakout Watchlists - newser.com
Ownership Capital B.V. Cuts Stock Holdings in Bio-Techne Corp $TECH - MarketBeat
Why Bio Techne Corporation stock could benefit from AI revolution2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Bio-Techne Corp $TECH Shares Purchased by Nisa Investment Advisors LLC - MarketBeat
Heatmap analysis for Bio Techne Corporation and competitorsCPI Data & Proven Capital Preservation Methods - newser.com
Is Bio Techne Corporation (TE1) stock positioned for secular growthTrade Entry Report & Risk Adjusted Swing Trade Ideas - newser.com
Can trapped investors hope for a rebound in Bio Techne Corporation2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com
How analysts revise price targets for Bio Techne Corporation (TE1) stockJuly 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
Bio-Techne (TECH) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
How Investors Are Reacting To Bio-Techne (TECH) Unveiling Its ProximityScope Spatial Biology Assay - Yahoo Finance
Bio-techne launches new assay for protein interaction visualization - Investing.com
Will Bio Techne Corporation benefit from macro trendsMarket Volume Summary & Low Drawdown Momentum Trade Ideas - newser.com
Bio-Techne (NASDAQ: TECH) launches ProximityScope on BOND RX for protein interactions - Stock Titan
How to use Fibonacci retracement on Bio Techne CorporationWeekly Market Report & Growth Focused Stock Pick Reports - newser.com
Is Bio Techne Corporation (TE1) stock a top hedge fund pick2025 Short Interest & Community Consensus Picks - newser.com
Will Bio Techne Corporation price bounce be sustainable2025 Sector Review & Stock Portfolio Risk Control - newser.com
4,462 Shares in Bio-Techne Corp $TECH Bought by Sage Mountain Advisors LLC - MarketBeat
First Citizens Bank & Trust Co. Sells 4,691 Shares of Bio-Techne Corp $TECH - MarketBeat
Can Bio Techne Corporation stock deliver consistent earnings growthJuly 2025 Volume & AI Optimized Trade Strategies - newser.com
Smart tools for monitoring Bio Techne Corporation’s price action2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com
What to expect from Bio Techne Corporation in the next 30 daysChart Signals & Community Trade Idea Sharing Platform - newser.com
What to do if you’re stuck in Bio Techne CorporationGap Down & Fast Entry and Exit Trade Plans - newser.com
Bio-Techne Corp $TECH Shares Bought by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Comparing Bio Techne Corporation in custom built stock radarsJuly 2025 Opening Moves & Fast Gaining Stock Reports - newser.com
Will Bio Techne Corporation stock benefit from sector rotationMarket Sentiment Review & Comprehensive Market Scan Reports - newser.com
How institutional ownership impacts Bio Techne Corporation stock2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com
Bio Techne Corp Stock (TECH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bio Techne Corp Stock (TECH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | 
|---|---|---|---|---|---|---|---|
| Nusse Roeland | Director | Aug 25 '25 | Sale | 56.36 | 17,040 | 960,388 | 44,559 | 
| BAUMGARTNER ROBERT V | Director | Aug 25 '25 | Option Exercise | 21.84 | 17,040 | 372,154 | 61,903 | 
| BAUMGARTNER ROBERT V | Director | Aug 25 '25 | Sale | 56.21 | 17,040 | 957,818 | 44,863 | 
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):
                 
            
         
                     
                             Get the Stockscreener App
                    Get the Stockscreener App